Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart wearables could alert nurses to patient danger sooner

NCT ID NCT05118477

Knowledge-focused Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a wearable monitoring system that tracks vital signs like heart rate and breathing continuously. The goal was to see if it helps hospital staff detect when surgical patients are getting worse faster than standard checks. 240 adults on a surgical ward took part, using small wrist or finger sensors. The trial focused on whether the system improves detection of deterioration and patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ambulatory monitoring system (wearable device)
What this could lead to
If successful, this system could help hospital staff spot when patients are getting worse sooner, potentially saving lives and improving recovery.
What could go wrong
This is a small feasibility study on one ward, so results may not apply to all hospitals or patients. The system may not work as well in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

240 people

The number who actually took part.

Started

Jul 2022

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient stable for at least 6 hours with at least one of the following: * NEWS2 \<= 2 and (in some exceptional NEWS \>2 confirmed with clinical staff, eg. patients with comorbidities). * Frequency of observations of \>4 hours at the time of randomisation. * Participant is willing and able to give informed consent for participation in the trial. * Male or Female, aged 18 years or above. * Any patient admitted to the participating surgical unit (including post-ICU patients) who are not currently monitored with standard continuous monitoring Exclusion Criteria: * The participant may not enter the trial if ANY of the following apply: * Intra-cardiac device * Monitored for less than 24 hours

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Deterioration, clinical are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Clinical Deterioration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Deterioration, clinical Surgery

Contacts and locations

Locations

  • Oxford University Hospitals Trust

    Oxford, Oxfordshire, OX3 9DU, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.